PP005—Risk perception and compliance in chronic myeloid leukaemia patients treated with tyrosine kinase inhibitors

PP005—Risk perception and compliance in chronic myeloid leukaemia patients treated with tyrosine kinase inhibitors

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical therapeutics 2013-08, Vol.35 (8), p.e18-e18
Hauptverfasser: Burdová, K, Friedecký, D, Faber, E, Strojil, J
Format: Artikel
Sprache:eng
Schlagworte:
Chronic myeloid leukemia
Internal Medicine
Leukemia
Medical Education
Patient education
Risk perception
Tyrosine
Tyrosine kinase inhibitors
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e18
container_issue 8
container_start_page e18
container_title Clinical therapeutics
container_volume 35
creator Burdová, K
Friedecký, D
Faber, E
Strojil, J
description
doi_str_mv 10.1016/j.clinthera.2013.07.044
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1426554288</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0149291813004256</els_id><sourcerecordid>3050362881</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2924-be1ab21a24974b5a18db03535fb087d3e931045549ca7b566fe1d192bb0f23e43</originalsourceid><addsrcrecordid>eNqNkcuKFEEQRQtRsB39BhNcVxn5qNdGGAZfMOAwzoC7JDMrio7u6swyM1vpnR8xX-iXWEWLgitXsbn3RsS5RfGSQ8WBN693lZvI5y1GUwngsoK2AqUeFRvetX3JufryuNgAV30pet49LZ6ltAMA2ddiU-SbG4D654-HW0p7NmN0OGcKnhk_MBcO80TGO2TkmdvG4MmxwwmnQAOb8Lg3eCDDZpMJfU4sRzQZB_ad8pblUwyJPLI9eZPWiC1ZyiGm58WT0UwJX_yeF8X9u7d3Vx_K60_vP15dXpdO9EKVFrmxghuh-lbZ2vBusCBrWY8WunaQ2EsOqq5V70xr66YZkQ-8F9bCKCQqeVG8OufOMXw9Ysp6F47RLys1V6JZnKLrFlV7Vrnl3hRx1HOkg4knzUGviPVO_0GsV8QaWr0gXpyXZycuT3wjjDq5BYTDgSK6rIdA_5Hx5p-MVUfOTHs8Yfp7sE5Cg_68Frn2yCWAEnUjfwE0k6Bl</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1426554288</pqid></control><display><type>article</type><title>PP005—Risk perception and compliance in chronic myeloid leukaemia patients treated with tyrosine kinase inhibitors</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Burdová, K ; Friedecký, D ; Faber, E ; Strojil, J</creator><creatorcontrib>Burdová, K ; Friedecký, D ; Faber, E ; Strojil, J</creatorcontrib><identifier>ISSN: 0149-2918</identifier><identifier>EISSN: 1879-114X</identifier><identifier>DOI: 10.1016/j.clinthera.2013.07.044</identifier><language>eng</language><publisher>Bridgewater: Elsevier Inc</publisher><subject>Chronic myeloid leukemia ; Internal Medicine ; Leukemia ; Medical Education ; Patient education ; Risk perception ; Tyrosine ; Tyrosine kinase inhibitors</subject><ispartof>Clinical therapeutics, 2013-08, Vol.35 (8), p.e18-e18</ispartof><rights>2013</rights><rights>Copyright Elsevier Limited Aug 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2924-be1ab21a24974b5a18db03535fb087d3e931045549ca7b566fe1d192bb0f23e43</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0149291813004256$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids></links><search><creatorcontrib>Burdová, K</creatorcontrib><creatorcontrib>Friedecký, D</creatorcontrib><creatorcontrib>Faber, E</creatorcontrib><creatorcontrib>Strojil, J</creatorcontrib><title>PP005—Risk perception and compliance in chronic myeloid leukaemia patients treated with tyrosine kinase inhibitors</title><title>Clinical therapeutics</title><subject>Chronic myeloid leukemia</subject><subject>Internal Medicine</subject><subject>Leukemia</subject><subject>Medical Education</subject><subject>Patient education</subject><subject>Risk perception</subject><subject>Tyrosine</subject><subject>Tyrosine kinase inhibitors</subject><issn>0149-2918</issn><issn>1879-114X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNkcuKFEEQRQtRsB39BhNcVxn5qNdGGAZfMOAwzoC7JDMrio7u6swyM1vpnR8xX-iXWEWLgitXsbn3RsS5RfGSQ8WBN693lZvI5y1GUwngsoK2AqUeFRvetX3JufryuNgAV30pet49LZ6ltAMA2ddiU-SbG4D654-HW0p7NmN0OGcKnhk_MBcO80TGO2TkmdvG4MmxwwmnQAOb8Lg3eCDDZpMJfU4sRzQZB_ad8pblUwyJPLI9eZPWiC1ZyiGm58WT0UwJX_yeF8X9u7d3Vx_K60_vP15dXpdO9EKVFrmxghuh-lbZ2vBusCBrWY8WunaQ2EsOqq5V70xr66YZkQ-8F9bCKCQqeVG8OufOMXw9Ysp6F47RLys1V6JZnKLrFlV7Vrnl3hRx1HOkg4knzUGviPVO_0GsV8QaWr0gXpyXZycuT3wjjDq5BYTDgSK6rIdA_5Hx5p-MVUfOTHs8Yfp7sE5Cg_68Frn2yCWAEnUjfwE0k6Bl</recordid><startdate>20130801</startdate><enddate>20130801</enddate><creator>Burdová, K</creator><creator>Friedecký, D</creator><creator>Faber, E</creator><creator>Strojil, J</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20130801</creationdate><title>PP005—Risk perception and compliance in chronic myeloid leukaemia patients treated with tyrosine kinase inhibitors</title><author>Burdová, K ; Friedecký, D ; Faber, E ; Strojil, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2924-be1ab21a24974b5a18db03535fb087d3e931045549ca7b566fe1d192bb0f23e43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Chronic myeloid leukemia</topic><topic>Internal Medicine</topic><topic>Leukemia</topic><topic>Medical Education</topic><topic>Patient education</topic><topic>Risk perception</topic><topic>Tyrosine</topic><topic>Tyrosine kinase inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Burdová, K</creatorcontrib><creatorcontrib>Friedecký, D</creatorcontrib><creatorcontrib>Faber, E</creatorcontrib><creatorcontrib>Strojil, J</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Clinical therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Burdová, K</au><au>Friedecký, D</au><au>Faber, E</au><au>Strojil, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PP005—Risk perception and compliance in chronic myeloid leukaemia patients treated with tyrosine kinase inhibitors</atitle><jtitle>Clinical therapeutics</jtitle><date>2013-08-01</date><risdate>2013</risdate><volume>35</volume><issue>8</issue><spage>e18</spage><epage>e18</epage><pages>e18-e18</pages><issn>0149-2918</issn><eissn>1879-114X</eissn><cop>Bridgewater</cop><pub>Elsevier Inc</pub><doi>10.1016/j.clinthera.2013.07.044</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0149-2918
ispartof Clinical therapeutics, 2013-08, Vol.35 (8), p.e18-e18
issn 0149-2918
1879-114X
language eng
recordid cdi_proquest_journals_1426554288
source Elsevier ScienceDirect Journals Complete
subjects Chronic myeloid leukemia
Internal Medicine
Leukemia
Medical Education
Patient education
Risk perception
Tyrosine
Tyrosine kinase inhibitors
title PP005—Risk perception and compliance in chronic myeloid leukaemia patients treated with tyrosine kinase inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T13%3A11%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PP005%E2%80%94Risk%20perception%20and%20compliance%20in%20chronic%20myeloid%20leukaemia%20patients%20treated%20with%20tyrosine%20kinase%20inhibitors&rft.jtitle=Clinical%20therapeutics&rft.au=Burdov%C3%A1,%20K&rft.date=2013-08-01&rft.volume=35&rft.issue=8&rft.spage=e18&rft.epage=e18&rft.pages=e18-e18&rft.issn=0149-2918&rft.eissn=1879-114X&rft_id=info:doi/10.1016/j.clinthera.2013.07.044&rft_dat=%3Cproquest_cross%3E3050362881%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1426554288&rft_id=info:pmid/&rft_els_id=1_s2_0_S0149291813004256&rfr_iscdi=true